Summary

Report Scope:

This report examines the current and future market potential of In Vitro Toxicity Testing Technologies. It offers a detailed analysis of the competitive environment, the regulatory scenario, technological advancements, drivers, restraints, opportunity and trends in market growth. This report covers market projections through 2026 and market rank for key market players. The report details the market shares of In Vitro Toxicity Testing Technologies segmented by toxicity endpoints and tests, tools/technology, components and end users.

This report segments the global market by geographic region: North America, Europe, Asia-Pacific and the Rest of the world. The North American region includes the U.S., Canada and Mexico, the European region (including Germany, U.K., France and the Rest of Europe), the Asia-Pacific region (including China, India, Japan and the Rest of Asia-Pacific). For market estimates, data is provided for the year 2019-2020 as the base year and forecast through year-end, 2026.

Report Includes:

- 132 data tables and 30 additional tables
- An updated review of the global markets for in vitro toxicity testing and technologies under development
- Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Technology assessment of the key drivers, restraints and opportunities that will shape the market for in vitro toxicity testing over the next five years (2021 to 2026)
- Evaluation and forecast the overall market size, and corresponding market share analysis by toxicity endpoints and tests, tool/technology, component, end-user industry and geographic region
- Highlights of COVID-19 implications on the progress of this market
- Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, Japan, China and India
- Review of key technology developments, latest market trends, and other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics and chemicals
- Insight into recent industry structure, current competitive landscape, R&D activities, and regulatory and legislative issues currently focused on in vitro toxicology testing
- Descriptive company profiles of the leading market players, including Abbott Laboratories Inc., GE Healthcare, PerkinElmer Inc., Qiagen NV and Thermo Fisher Scientific Inc.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Update
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction
Chapter 4 Regulatory Framework and Programs
Medical Device Definition and Classification
Regulations
U.S.
Europe
Regulatory Timeline
Chapter 5 Market Dynamics
Market Dynamics
Market Drivers
Market Restraints
Opportunities
Chapter 6 Impact of COVID-19 Pandemic
Introduction
Outbreak
Symptoms of COVID-19
Progression of COVID-19
Incubation Period
Epidemiology
Global Confirmed COVID-19 Cases and Deaths
Collaboration
Spread of Disease
Current Status and Impact on Medtech
Elective and Noncritical Procedures
Shift in Manufacturing
Regulatory Delays, Clinical Trials and Product Launches
Supply Chain Disruptions
Medical Tourism
Government and Private Funds
EUA for Diagnostic Kits and Devices
COVID-19: Global Landscape of Vaccine Development
Chapter 7 Market Breakdown by Toxicity Endpoint and Test
Global Market for In Vitro Toxicity by Toxicity Endpoint and Test
Market Size and Forecast
ADME
Genotoxicity Testing
Cytotoxicity Testing
Ocular Toxicity
Organ Toxicity
Skin Irritation, Corrosion and Sensitization
Phototoxicity Testing
Dermal Toxicity
Carcinogenicity
Neurotoxicity
Development and Reproductive Toxicity (DART)
Other Toxicity Endpoints and Tests
Chapter 8 Market Breakdown by Tool/Technology
Global Market for In Vitro Toxicity by Tool/Technology
Market Size and Forecast
Transcriptomics
Proteomics
Metabolomics
Cellomics or Cytomics
Chapter 9 Market Breakdown by Component
Global Market for In Vitro Toxicity Testing Technology by Component
Market Size and Forecast
Equipment
Reagents and Kits
Software and Analytics
Services
Chapter 10 Market Breakdown by End User
Global Market for In Vitro Toxicity Testing by End User
Market Size and Forecast
Pharmaceutical and Biotechnology
Food and Beverage Industry
Healthcare (Diagnosis)
Chemical Industry
CROs
Research Institutes
Personal Care Products (Cosmetics)
Chapter 11 Market Breakdown by Region
Global Market for In Vitro Toxicity Testing by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 12 Competitive Landscape
In Vitro Toxicity Testing
Global Company Share Analysis
In Vitro Toxicity Testing Market Players
Chapter 13 Company Profiles
Key Players
ABBOTT LABORATORIES, INC.
AGILENT TECHNOLOGIES INC.
GE HEALTHCARE
PERKINELMER INC.
QIAGEN NV
THERMO FISHER SCIENTIFIC INC.
Other Market Players
ACEA BIOSCIENCES INC.
ALBANY MOLECULAR RESEARCH INC.
APTUIT INC.
BIOGNOSYS AG
BIORELIANCE
BIOVIA
CELLULAR DYNAMICS INTERNATIONAL INC.
CHANTEST
CHARLES RIVER LABORATORIES
COVANCE INC.
CYPROTEX PLC
DRIK LLC
ENZO LIFE SCIENCES INC.
ESSEN BIOSCIENCE INC.
EUROFINS SCIENTIFIC SE
EVOTEC AG
GENEDATA
GENTRONIX LTD.
HUREL CORP.
IMQUEST BIOSCIENCES INC.
IMSTAR SA
INSPHERO AG
KIYATEC INC.
LONZA GROUP LTD.
METABOLON INC.
MOLECULAR DEVICES LLC
PROMEGA CORP.
SGS-SA
STEMINA BIOMARKER DISCOVERY INC.
SYNVIVO, INC.
VALA SCIENCES INC.
VISTAGEN THERAPEUTICS INC.
XENOMETRIX AG
Chapter 14 Appendix: List of Acronyms